Ankylosing spondylitis is a chronic inflammatory disease of unknown etiology that can lead to severe pain, disability and a heavy economic and social burden. The preliminary survey of prevalence in China is about 0.3%. If we take our population of 1.4 billion people, there are 4.2 million people with ankylosing spondylitis. In addition, the disease is more prevalent in young and middle-aged men, many patients have moved around the country, alternating between Western and Chinese medicine, or not to control the disease, “cure” the disease. The reason for this is that medical treatment is not yet a cure for ankylosing spondylitis, and many patients are eager to seek medical attention and easily induced by misinformation, resulting in overtreatment, irrational treatment, resulting in a huge waste of social medical resources. Many people have been going to the doctor for many years, but they only deeply appreciate why ankylosing spondylitis should be treated, and do not understand what ankylosing spondylitis can cure. In short, it is the futility of running around, not knowing the goals of ankylosing spondylitis treatment. The Chinese Medical Association Rheumatology Society’s 2010 guidelines for the diagnosis and treatment of ankylosing spondylitis boil down the goals of treatment for ankylosing spondylitis to the following five points. 1. Resolution of signs and symptoms: Eliminate or minimize symptoms such as back pain, morning stiffness and fatigue to the greatest extent possible. 2, restore function: to maximize the restoration of physical functions, such as spinal mobility, social mobility and work ability of the patient. 3. Prevent joint damage: To prevent new bone formation, bone destruction, bony ankylosis and spinal deformation in patients with involvement of the hip, shoulder, mid-shaft and peripheral joints. 4., improve the quality of life of patients: including socio-economic factors, work, sickness retirement, retirement, etc. 5., Prevent complications of spinal diseases: prevent spinal fractures, flexion contractures, especially in the cervical spine. Studying the above 5 points, we will find that the current target of ankylosing spondylitis treatment is still the process of inflammation rather than the cause of inflammation. In the case of ankylosing spondylitis, we can currently only control the inflammation, improve function, and provide help, not “cure” the disease. In fact, patients with clinical ankylosing spondylitis can have their symptoms controlled and their prognosis improved with timely diagnosis and reasonable treatment. In particular, the emergence of biologic agents in recent years has made the inflammatory manifestations of ankylosing spondylitis disappear more quickly and with longer-lasting effects, but this is still not a cure, and the condition can still recur. The course of ankylosing spondylitis is characterized by alternating episodes of remission and remission, which can sometimes cause serious frustration for the patient, coupled with the possibility of not receiving a satisfactory return for the financial effort. As a doctor, understanding this, you can inform the patient as early as possible, not to seek a “cure” and run around, spending money; as patients understand this, it helps to adjust the mindset, no longer superstitious “cure” type of advertising, less detours, as early as possible to the regular The hospital will accept reasonable treatment recommendations as soon as possible.